Large Animal

Collaborative Research at VGL Expands Knowledge of Equine Genome

May 26, 2021
A recent publication co-authored by VGL researchers and other members of the equine genetics research community highlights how collaborative work, including an “adopt-a-tissue” initiative, have allowed researchers to annotate tissue-specific elements of the equine genome.

New Name for Immune-Mediated Myositis (IMM) Test

January 11, 2021
To more accurately reflect the genetic mechanism that underpins both immune-mediated myositis (IMM) and non-exertional rhabdomyolysis, the name of the VGL’s DNA test has been updated from Immune-mediated Myositis (IMM/MYH1) to myosin-heavy chain myopathy (MYHM).

VGL-led Team Identifies Genetic Variant Associated with Distichiasis in Friesians

December 04, 2020
An interdisciplinary team led by VGL Director Dr. Rebecca Bellone identified a genetic variant associated with distichiasis in Friesian horses. This is the first identification of a genetic variant linked to equine distichiasis, an ocular disease characterized by eyelashes that grow from abnormal positions along the edge of the eyelid and often lead to corneal irritation and damage.

VGL's Dr. Rebecca Bellone Featured in Equine Veterinary Journal Podcast

May 21, 2020
In early April, VGL Director Dr. Rebecca Bellone joined the Equine Veterinary Journal podcast "EVJ in Conversation" to discuss catastrophic breakdown in racehorses as well as her recent paper, which found no evidence of linkage between catastrophic breakdown and the mutation that causes Warmblood fragile foal syndrome type 1 (WFFS).